^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MB-CART20.1

    i
    Other names: MB-CART20.1, MB CART20.1, anti-CD20 CAR T cells, MBCART20.1
    Associations
    News
    Trials
    Company:
    Miltenyi Biotec
    Drug class:
    CD20-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials